Bittium Introduces Innovative Faros Pro ECG Device and EasyFlex Electrode for Extended Monitoring

Bittium Launches New Electrocardiogram Monitoring Solutions

On August 27, 2026, Bittium Corporation announced the launch of its innovative ambulatory ECG device, the Bittium Faros Pro™, alongside the Bittium EasyFlex™, a single-use electrode patch aimed at streamlining long-term ECG monitoring. This launch signifies a major expansion for Bittium’s product lineup, focusing on improving healthcare professionals’ capability to monitor and assess heart health effectively, especially outside of conventional hospital settings.

Significance of the Launch

The Bittium Faros Pro is designed to record high-quality ECG signals in real-time. It allows patients to go about their daily activities while being monitored, which is crucial for capturing sporadic arrhythmias that typically occur unpredictably during normal life. This device can keep recording ECG data for extended periods, ranging from 24 hours up to 30 days, making it a powerful tool for modern cardiovascular health monitoring.

Bittium’s dedication to advancing ECG technology is complemented by the EasyFlex electrode patch, intended for one-time use, ensuring ease of application and comfort for the patients. These two products together aim to facilitate better monitoring practices and provide critical data that healthcare providers need to make informed decisions regarding patient care.

Unmatched Quality and Reliability

Healthcare professionals rely heavily on the quality of ECG signals when diagnosing and treating heart conditions. Bittium has a long-standing reputation in physiological signal measurement, which is evidenced by the delivery of over 600,000 Faros devices across more than 40 countries. The newly launched Faros Pro device builds on this foundation, ensuring that clinicians receive reliable data that can lead to timely interventions who might otherwise suffer from undiagnosed heart issues.

Naomi Huikuri, Senior Vice President of the Medical Business Segment at Bittium, emphasized the importance of this launch, noting how critical it is to merge user-friendly devices with decades of expertise in biosignal measurement. Longer periods of ECG monitoring allow for the detection of arrhythmias that might be missed during shorter assessments, enabling patients to receive timely care and potentially averting serious complications such as strokes.

Features of Faros Pro

The Bittium Faros Pro device is meticulously engineered to maintain operational integrity for up to 21 days on a single charge while adapting to various user needs depending on device settings. This level of endurance provides healthcare professionals with extensive opportunities to monitor patients thoroughly, making it easier to assess heart rhythm events effectively.

This device is now CE marked and complies with the EU Medical Device Regulation (EU) 2017/745. Bittium plans to display the Faros Pro and the EasyFlex at the upcoming ESC Congress 2026 in Munich, Germany, underscoring their commitment to enhancing cardiac monitoring technology.

The Future of ECG Monitoring

Bittium's advancements in ECG devices showcase not only their commitment to healthcare innovation but also their strategic direction in expanding their international ECG offerings. With plans to continually enhance and incorporate cutting-edge technology in future ECG solutions, Bittium aims to improve medical standards and pave the way for more comprehensive heart health solutions worldwide.

In summary, the introduction of the Faros Pro and EasyFlex is a significant milestone for Bittium and a valuable advancement in the broader field of cardiology. As this technology evolves, it holds the promise of improving diagnosis and patient outcomes through better heart monitoring solutions.

For more detailed information regarding this innovative product, visit the official Bittium website at Bittium Faros Pro.